AACPN Launches Psychedelic Research Initiative to Advance Veteran Mental Health Innovation
- Adrian Bruneau

- 4 hours ago
- 2 min read
The American Alternative Care Policy Network (AACPN) this week launched its Psychedelic Research Initiative to support continued scientific research into emerging therapies that may help address some of America's most difficult mental health challenges.
At the center of this effort are veterans.

For many veterans, the invisible wounds of service can persist long after they return home. Post-traumatic stress, depression, anxiety, traumatic brain injury, substance-use disorders, and related conditions continue to affect thousands of former service members and their families. While many veterans benefit from existing treatments, others continue to struggle despite years of care.
AACPN believes these Americans deserve every opportunity for safe, evidence-based innovation.
A growing body of research is examining the potential role of psychedelic-assisted therapies—including treatments involving psilocybin, MDMA, ketamine, and other compounds—in addressing trauma-related conditions. Researchers, policymakers, veterans' organizations, and healthcare institutions across the country are increasingly exploring whether these therapies may offer new pathways for recovery when conventional approaches fall short.
The AACPN initiative is not about promoting recreational drug use or bypassing scientific standards. It is about supporting rigorous research, responsible regulation, and informed public discussion. As evidence continues to emerge, policymakers should ensure that promising therapies receive fair evaluation and that patients have access to treatments proven to be safe and effective.
Although veterans remain a primary focus, AACPN recognizes that trauma affects many Americans. First responders, survivors of violence, healthcare workers, and others exposed to significant psychological stress may also benefit from continued research into innovative mental health treatments.
AACPN launched this campaign because too many Americans are still searching for answers. By supporting science, encouraging research, and elevating the voices of those living with trauma, we can help build a healthcare system that offers more hope, more options, and better outcomes for those who have sacrificed the most.


Comments